Swiss companies have become some of the most important foreign investors in the United States. Despite Switzerland’s small population of about eight million people, its businesses have made a big impact on the U.S. economy. They create thousands of jobs, support vital research, and build strong economic ties between the two countries.
Switzerland’s Role as a Major Foreign Investor in the U.S.
Switzerland ranks among the world’s top countries investing directly in the United States. In 2022 alone, Swiss companies invested around $307 billion in the U.S., making Switzerland the seventh-largest foreign investor in the country. This is a remarkable achievement given Switzerland’s relatively small population.
Such a large volume of investment shows Swiss companies’ confidence in the American market and their commitment to expanding their operations there. This steady investment helps to strengthen economic ties between the two nations and encourages further business collaboration.
Creating Hundreds of Thousands of Jobs Across the U.S.
Swiss investments in the U.S. support over 500,000 American jobs across all 50 states. These jobs range from manufacturing and production to research, development, and high-skilled technical roles. Many Swiss companies offer competitive salaries, with wages often among the highest for foreign-owned firms in the U.S.
Swiss businesses are leaders in investing in research and development in the U.S. In 2022, Swiss affiliates spent roughly $15 billion on research and department more than any other foreign country. This investment has created over 22,500 jobs in fields such as technology, pharmaceuticals, medical devices, and manufacturing improvements.
Swiss firms’ strong focus on innovation helps push the U.S. forward in developing new products and technologies.
Roche’s Bold Commitment to U.S. Manufacturing and Jobs
One of the most notable examples of Swiss investment is Roche, a leading pharmaceutical company. Roche recently announced a historic $50 billion investment in U.S. manufacturing and research over the next five years. This initiative is expected to create more than 12,000 new jobs across multiple states, including Pennsylvania, Indiana, and Massachusetts.
Roche plans to build advanced facilities focused on producing medicines and conducting cutting-edge research. This massive investment shows Swiss companies’ long-term commitment to the U.S. economy, even as trade tensions and tariffs present challenges.
Strong Bonding on Swiss-U.S. Economic Partnership
Swiss investment in the United States goes beyond dollars and jobs it strengthens a deep economic partnership built on trust, shared values, and mutual growth. Swiss-owned companies contribute to many vital industries such as pharmaceuticals, finance, manufacturing, and real estate.
They also support U.S. exports, with Switzerland ranking as a top trading partner for American goods and services. This partnership encourages innovation, creates jobs, and fosters economic stability on both sides. By investing in the U.S., Swiss companies help build a stronger future for both nations.
